New blood test could cut unnecessary transfusions in liver patients

NCT ID NCT07437755

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares a new method using ROTEM (a rapid blood clotting test) to standard care for deciding whether to give blood products before high-risk procedures in patients with decompensated liver cirrhosis. The goal is to see if the ROTEM-guided approach reduces the number of patients receiving transfusions while keeping bleeding complications low. About 116 adults will be randomly assigned to either the ROTEM-guided strategy or usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Blood products transfusion (platelets, fresh frozen plasma, cryoprecipitate) guided by ROTEM testing
What this could lead to
If successful, this could lead to fewer unnecessary blood transfusions and safer procedures for patients with liver cirrhosis.
What could go wrong
This is a small, single-center trial, so results may not apply broadly. The ROTEM-guided approach may not reduce bleeding or transfusions as hoped.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DECOMPENSATED LIVER CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Institute of Gastroenterology and Hepatology

    RECRUITING

    Iași, Iaşi, 700111, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.